Tag: biopharmaceutical
MSD announces new regional president amid COVID-19 research
MSD, a trade name of US-based biopharmaceutical company Merck & Co., Inc., have revealed a new President for its Human Health Division in Asia Pacific: David Peacock, appointed from February 1, 2022. David brings a broad range of experience and perspectives to MSD from previous senior roles in the UK, US, and across Asia. “I […]
Gyros Expands Asian Distribution to Singapore
SINGAPORE – Gyros’ nanoliter-scale immunoassay platform is now available to biopharmaceutical companies in Singapore. Gyrolab xP workstation is used by major biopharmaceutical companies and their service providers worldwide to improve productivity and efficiency during the development of biotherapeutics and vaccines, boosting time-critical workflows and helping to meet regulatory demands. “We are very pleased to expand […]
